MENU
+Compare
TSBX
Stock ticker: NASDAQ
AS OF
Jun 26 closing price
Price
$0.33
Change
-$0.03 (-8.33%)
Capitalization
7.69M

TSBX Turnstone Biologics Corp Forecast, Technical & Fundamental Analysis

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors... Show more

TSBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TSBX with price predictions
Jun 25, 2025

TSBX saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for TSBX moved out of overbought territory on June 25, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 13 similar instances where the indicator exited the overbought zone. In of the 13 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TSBX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 03, 2025. You may want to consider a long position or call options on TSBX as a result. In of 38 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TSBX just turned positive on June 03, 2025. Looking at past instances where TSBX's MACD turned positive, the stock continued to rise in of 17 cases over the following month. The odds of a continued upward trend are .

TSBX moved above its 50-day moving average on June 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TSBX crossed bullishly above the 50-day moving average on June 12, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where TSBX advanced for three days, in of 80 cases, the price rose further within the following month. The odds of a continued upward trend are .

TSBX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 15 cases where TSBX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.385) is normal, around the industry mean (16.539). P/E Ratio (0.000) is within average values for comparable stocks, (59.016). TSBX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.300). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (1.653) is also within normal values, averaging (255.605).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TSBX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TSBX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
TSBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TSBX is expected to report earnings to rise 33.33% to -68 cents per share on August 13

Turnstone Biologics Corp TSBX Stock Earnings Reports
Q2'25
Est.
$-0.68
Q1'25
Beat
by $0.17
Q4'24
Beat
by $0.20
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.15
The last earnings report on May 09 showed earnings per share of -50 cents, beating the estimate of -68 cents. With 148.61K shares outstanding, the current market capitalization sits at 7.69M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
9310 Athena Circle
Phone
+1 347 897-5988
Employees
80
Web
https://www.turnstonebio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OUT16.410.61
+3.86%
OUTFRONT Media Inc
MERC3.480.07
+1.90%
Mercer International
NWSA29.540.14
+0.48%
News Corp
LPTH3.14N/A
N/A
LightPath Technologies
AQB0.77N/A
-0.63%
AquaBounty Technologies

TSBX and Stocks

Correlation & Price change

A.I.dvisor tells us that TSBX and FBLG have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TSBX and FBLG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSBX
1D Price
Change %
TSBX100%
-4.40%
FBLG - TSBX
27%
Poorly correlated
-3.43%
ARQT - TSBX
27%
Poorly correlated
+0.98%
CHRS - TSBX
26%
Poorly correlated
-6.08%
FULC - TSBX
25%
Poorly correlated
-0.42%
DYN - TSBX
25%
Poorly correlated
-1.98%
More